Javascript must be enabled to continue!
Erlotinib-related bilateral anterior uveitis: Figure 1
View through CrossRef
The authors report the case of a 68-year-old woman with secondary adenocarcinoma of the lungs from an unknown primary. Erlotinib was started which produced symptoms suggestive of uveitis. Erlotinib was stopped and restarted a month later at a lower dose, which resulted in severe bilateral anterior uveitis. The uveitis settled after stopping erlotinib and treatment with topical steroids and cycloplegics. To the best of the authors’ knowledge, this is the first case of erlotinib-related anterior uveitis.
Title: Erlotinib-related bilateral anterior uveitis: Figure 1
Description:
The authors report the case of a 68-year-old woman with secondary adenocarcinoma of the lungs from an unknown primary.
Erlotinib was started which produced symptoms suggestive of uveitis.
Erlotinib was stopped and restarted a month later at a lower dose, which resulted in severe bilateral anterior uveitis.
The uveitis settled after stopping erlotinib and treatment with topical steroids and cycloplegics.
To the best of the authors’ knowledge, this is the first case of erlotinib-related anterior uveitis.
Related Results
Uveitis in Adults
Uveitis in Adults
ImportanceUveitis is characterized by inflammation of the uvea—the middle portion of the eye composed of the iris, ciliary body, and choroid—causing eye redness, pain, photophobia,...
Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period
Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period
Objectives: The aim of this study was to establish the etiology of uveitis and to examine its relationship with anatomical localization, age, and gender. Methods: A prospective stu...
Mechanisms of Enhanced Radiation Response following Epidermal Growth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva)
Mechanisms of Enhanced Radiation Response following Epidermal Growth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva)
Abstract
Erlotinib (Tarceva) is an orally available HER1 (epidermal growth factor receptor, EGFR) tyrosine kinase inhibitor advancing through clinical trials for the...
Symptoms and signs of anterior uveitis
Symptoms and signs of anterior uveitis
AbstractPurpose To review the symptoms and signs of anterior ueveitis (AU), based on the anatomic classification of uveitis, iritis and iridocyclitis.Methods Review of symptoms and...
Follow-up of erlotinib related uveitis
Follow-up of erlotinib related uveitis
The authors report the follow-up of a 68-year-old lady with bilateral anterior uveitis secondary to erlotinib. Erlotinib was started and stopped after symptoms and signs suggestive...
Association between uveitis onset and economic development in mainland China
Association between uveitis onset and economic development in mainland China
Abstract
Background
Economic prosperity has fostered numerous changes that may translate into better or worse outcomes across all domains of health. This study aims to exp...
Pattern of uveitis in tertiary care hospital in Tripura, India
Pattern of uveitis in tertiary care hospital in Tripura, India
Introduction:
Uveitis is characterized by inflammation of uveal tissue which can lead to significant loss of vision if not treated promptly. The uveitis pattern differs...
PREVALENCE AND COMPARISON OF UVEITIS IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH POSITIVE AND NEGATIVE ANTI-NUCLEAR ANTIBODIES AT A TERTIARY CARE HOSPITAL
PREVALENCE AND COMPARISON OF UVEITIS IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH POSITIVE AND NEGATIVE ANTI-NUCLEAR ANTIBODIES AT A TERTIARY CARE HOSPITAL
Background: Juvenile Idiopathic Arthritis (JIA) is the most common pediatrics rheumatic disease, with uveitis as a masquerading and severe extra-articular manifestation causing maj...

